PFKFB3 and cancer: Unlike cancer cells and iPS, fibroblasts were unaffected by 3PO treatment, which was similar to a previous report showing that transformed fibroblasts (PFKFB3+/−) are more sensitive to this inhibitor than wild-type control fibroblasts (PFKFB3+/+) [39].